ADRIANA ACOSTA-PROWS: Open Payments
NPI 1699161513 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 8 companies in 2025. Trend: 2023 $71 · 2024 $51 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Eisai Inc. | 1 | $31 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REBYOTA, TRELEGY ELLIPTA, CLENPIQ, Leqembi, WAKIX, OFEV, INSPIRE, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
